InvestorsHub Logo
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

Re: None

Monday, 12/05/2016 9:29:46 PM

Monday, December 05, 2016 9:29:46 PM

Post# of 6035
Opdivo + Yervoy results released in Austria are encouraging. I wonder how much HS-120 might add to the efficacy. I also wonder if adding HS-120 might allow for lower doses so that these drugs might be both more tolerable and safer.

http://www.businesswire.com/news/home/20161205005347/en/Encouraging-Survival-Observed-Opdivo-nivolumab-Yervoy-ipilimumab

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News